Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319040147> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4319040147 abstract "Abstract Since the high burden of chronic migraine (CM), it is challenging to identify the best prevention treatment. Based on the preclinical evidences about the different therapeutic targets of OnabotulinumtoxinA (BT-A), acting on C-fibers and anti-CGRP monoclonal antibodies (mAbs) acting on Aδ-fibers, the rationale of using as alternative or combining therapies has been hypothesized. Until now, the association of BT-A and mAbs has been poorly investigated. This study aimed to evaluate whether mAbs is effective and safe in CM patients previously treated with BT-A, either as alternative or add-on treatment. We enrolled 47 patients: according to the response to BT-A treatment, patients were defined Non-responder (NR) and Partial-responder (PR). NR were shifted to mAbs. PR were randomly divided into those who added mAbs therapy (PR-P) and those who shifted treatment (PR-S), interrupting BT-A. Clinical variables were collected at baseline, after three and six months. Study results evidenced the efficacy of mAbs in improving clinical outcomes in CM patients, with a better response in PR group. No statistically significant differences of clinical changes were observed between PR-P and PR-S groups. No safety concerns were raised in combined treatments. Preventive prophylaxis with mAbs is effective, even in difficult to treat CM patients. Further studies, with a larger sample size, are needed to highlight a potential additive effect of combined therapies." @default.
- W4319040147 created "2023-02-03" @default.
- W4319040147 creator A5013044201 @default.
- W4319040147 creator A5028095950 @default.
- W4319040147 creator A5032023638 @default.
- W4319040147 creator A5040220962 @default.
- W4319040147 creator A5050119083 @default.
- W4319040147 creator A5077683609 @default.
- W4319040147 creator A5077761581 @default.
- W4319040147 creator A5090843973 @default.
- W4319040147 date "2023-02-02" @default.
- W4319040147 modified "2023-09-28" @default.
- W4319040147 title "Anti-cgrp Monoclonal Antibodies in Chronic Migraine Prophilaxys: Efficacy and Safety in Patients Treated With Botulinum Toxin a" @default.
- W4319040147 doi "https://doi.org/10.21203/rs.3.rs-2513021/v1" @default.
- W4319040147 hasPublicationYear "2023" @default.
- W4319040147 type Work @default.
- W4319040147 citedByCount "0" @default.
- W4319040147 crossrefType "posted-content" @default.
- W4319040147 hasAuthorship W4319040147A5013044201 @default.
- W4319040147 hasAuthorship W4319040147A5028095950 @default.
- W4319040147 hasAuthorship W4319040147A5032023638 @default.
- W4319040147 hasAuthorship W4319040147A5040220962 @default.
- W4319040147 hasAuthorship W4319040147A5050119083 @default.
- W4319040147 hasAuthorship W4319040147A5077683609 @default.
- W4319040147 hasAuthorship W4319040147A5077761581 @default.
- W4319040147 hasAuthorship W4319040147A5090843973 @default.
- W4319040147 hasBestOaLocation W43190401471 @default.
- W4319040147 hasConcept C118303440 @default.
- W4319040147 hasConcept C126322002 @default.
- W4319040147 hasConcept C141071460 @default.
- W4319040147 hasConcept C159654299 @default.
- W4319040147 hasConcept C163170386 @default.
- W4319040147 hasConcept C170493617 @default.
- W4319040147 hasConcept C203014093 @default.
- W4319040147 hasConcept C2777478456 @default.
- W4319040147 hasConcept C2778541695 @default.
- W4319040147 hasConcept C2910587157 @default.
- W4319040147 hasConcept C542903549 @default.
- W4319040147 hasConcept C71924100 @default.
- W4319040147 hasConceptScore W4319040147C118303440 @default.
- W4319040147 hasConceptScore W4319040147C126322002 @default.
- W4319040147 hasConceptScore W4319040147C141071460 @default.
- W4319040147 hasConceptScore W4319040147C159654299 @default.
- W4319040147 hasConceptScore W4319040147C163170386 @default.
- W4319040147 hasConceptScore W4319040147C170493617 @default.
- W4319040147 hasConceptScore W4319040147C203014093 @default.
- W4319040147 hasConceptScore W4319040147C2777478456 @default.
- W4319040147 hasConceptScore W4319040147C2778541695 @default.
- W4319040147 hasConceptScore W4319040147C2910587157 @default.
- W4319040147 hasConceptScore W4319040147C542903549 @default.
- W4319040147 hasConceptScore W4319040147C71924100 @default.
- W4319040147 hasLocation W43190401471 @default.
- W4319040147 hasOpenAccess W4319040147 @default.
- W4319040147 hasPrimaryLocation W43190401471 @default.
- W4319040147 hasRelatedWork W2396881813 @default.
- W4319040147 hasRelatedWork W2883290297 @default.
- W4319040147 hasRelatedWork W2990089107 @default.
- W4319040147 hasRelatedWork W3014384731 @default.
- W4319040147 hasRelatedWork W3106051880 @default.
- W4319040147 hasRelatedWork W3116524452 @default.
- W4319040147 hasRelatedWork W3126068273 @default.
- W4319040147 hasRelatedWork W3199883053 @default.
- W4319040147 hasRelatedWork W3207819762 @default.
- W4319040147 hasRelatedWork W3207849898 @default.
- W4319040147 isParatext "false" @default.
- W4319040147 isRetracted "false" @default.
- W4319040147 workType "article" @default.